Lewy Body Dementia Clinical Trials

5 recruiting

Lewy Body Dementia Trials at a Glance

12 actively recruiting trials for lewy body dementia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Gainesville, Brescia, and Aventura. Lead sponsors running lewy body dementia studies include Association de Recherche Bibliographique pour les Neurosciences, Eastern Switzerland University of Applied Sciences, and ACADIA Pharmaceuticals Inc..

Browse lewy body dementia trials by phase

Treatments under study

About Lewy Body Dementia Clinical Trials

Looking for clinical trials for Lewy Body Dementia? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lewy Body Dementia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lewy Body Dementia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.180 enrolled54 locationsNCT07029581
Recruiting

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

Parkinson DiseaseMSA - Multiple System AtrophyLewy Body Dementia (LBD)+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta180 enrolled3 locationsNCT06846658
Recruiting
Phase 2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Lewy Body Dementia (LBD)Parkinson Disease (PD)
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)20 enrolled1 locationNCT07176286
Recruiting
Not Applicable

Transcranial Alternating Current Stimulation in Lewy Body Dementia

Lewy Body Dementia (LBD)Transcranial Alternating Current Stimulation
IRCCS Centro San Giovanni di Dio Fatebenefratelli40 enrolled1 locationNCT07375771
Recruiting

Parkinson's Disease and Movement Disorders Clinical Database

Parkinson DiseaseParkinson Disease DementiaLewy Body Dementia With Behavioral Disturbance+1 more
University of Pennsylvania250 enrolled1 locationNCT04997642
Recruiting
Not Applicable

tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden

Dementia With Lewy BodiesLewy Body DiseaseLewy Body Dementia+2 more
Association de Recherche Bibliographique pour les Neurosciences30 enrolled1 locationNCT06785948
Recruiting
Not Applicable

Telehealth in Lewy Body Dementia

Lewy Body DiseaseLewy Body Dementia With Behavioral DisturbanceLewy Body Parkinson Disease
University of Florida106 enrolled1 locationNCT05014971
Recruiting
Not Applicable

PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia

Dementia With Lewy BodiesLewy Body DiseaseLewy Body Dementia+1 more
Rush University Medical Center622 enrolled1 locationNCT06389032
Recruiting

Investigating Genetic Status in Patients Presenting to Clinic

Alzheimer Dementia (AD)Lewy Body Dementia (LBD)Dementia, Frontotemporal
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1,000 enrolled1 locationNCT05911932
Recruiting

North American Prodromal Synucleinopathy Consortium Stage 2

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+3 more
Washington University School of Medicine500 enrolled9 locationsNCT05826457
Recruiting
Not Applicable

Exergaming Revolution in Dementia

Alzheimer DiseaseParkinson DiseaseLewy Body Dementia+2 more
Eastern Switzerland University of Applied Sciences48 enrolled1 locationNCT06631742
Recruiting
Phase 2

Safety and Efficacy of AR1005 in Patients with Lewy Body Disease

Lewy Body Dementia
Yonsei University60 enrolled1 locationNCT06537076